As shown in Figure 3B, the increase in cyclin B1 and cyclin A2 and the decrease in cyclin E1 were observable in AdoMet-treated GBM cells, while cyclin D1 appeared downregulated in U251MG and U87MG cells and slightly upregulated in U343MG cells. This evidence concerns the gene CCND1 and glioblastoma.